Citadel Advisors’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-630
Closed -$5.17K 14469
2025
Q1
$5.17K Buy
+630
New +$6.21K ﹤0.01% 13836
2022
Q2
Sell
-544
Closed -$213K 13807
2022
Q1
$213K Buy
544
+257
+90% +$77.1K ﹤0.01% 11378
2021
Q4
$101K Sell
287
-11,587
-98% -$5.53M ﹤0.01% 12718
2021
Q3
$5.85M Buy
11,874
+11,054
+1,348% +$5.45M ﹤0.01% 4005
2021
Q2
$406K Buy
+820
New +$402K ﹤0.01% 10526

Other funds holding PIII

Citadel Advisors's PIII Position: Q2 2025 in Review

Citadel Advisors sold out of P3 Health Partners (PIII) in Q2 2025, closing a stake of 630 shares — an estimated $5.17K sold.

Citadel Advisors first reported a position in PIII in Q2 2021 and held it in 5 quarters. The position peaked at $5.85M in Q3 2021. 16 funds tracked by Wall St. Rank hold PIII as of Q2 2025.

  • Citadel Advisors reported no remaining P3 Health Partners position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 630 P3 Health Partners shares in Q2 2025, an estimated $5.17K.
  • Citadel Advisors first reported a position in P3 Health Partners in Q2 2021 and held it in 5 quarters.
  • Citadel Advisors's P3 Health Partners position peaked at $5.85M in Q3 2021.
  • 16 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.